Emerging evidence regarding statins use as novel endometriosis targeted treatment: real “magic pills” or “trendy” drugs? Some considerations

Amerigo Vitagliano; Vitagliano A; Marco Noventa; Noventa M; Gizzo S; Salvatore Gizzo

doi:10.1016/j.ejogrb.2014.11.018

Emerging evidence regarding statins use as novel endometriosis targeted treatment: real “magic pills” or “trendy” drugs? Some considerations

Amerigo Vitagliano, Vitagliano A, Marco Noventa, Noventa M, Gizzo S, Salvatore Gizzo

European journal of obstetrics, gynecology, and reproductive biology · 2014 · vol. 184 , pp. 125–126 · doi:10.1016/j.ejogrb.2014.11.018 · PMID:25524715 · W2035412713

letter OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This paper reviews emerging evidence concerning the use of statins as a novel targeted treatment for endometriosis, evaluating whether they represent a promising therapeutic option or merely a transient trend.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hydroxymethylglutaryl-CoA Reductase Inhibitors Endometriosis Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations 2014

References (5)

Lowering Low Density Lipoprotein Cholesterol with Simvastatin, a Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Does Not Affect Luteal Function in Premenopausal Women via openalex
Novel Therapies Targeting Endometriosis via openalex
W1970575212 via openalex
W2101386379 via openalex
W2114220878 via openalex

Cited by (1)

Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations 2014

Source provenance

europepmc: last seen: 2026-09-25T06:10:54.854274+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:18:10.358439+00:00

License: CC0 · commercial use OK

[1] Novel Therapies Targeting Endometriosis 2011

[2] Lowering Low Density Lipoprotein Cholesterol with Simvastatin, a Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Does Not Affect Luteal Function in Premenopausal Women 2002